Abstract:Abstract The primary mechanism of secondary injury after cerebral ischemia may be the brain inflammation that emerges after an ischemic stroke, which promotes neuronal death and inhibits nerve tissue regeneration. As the first immune cells to be activated after an ischemic stroke, microglia play an important immunomodulatory role in the progression of the condition. After an ischemic stroke, peripheral blood immune cells (mainly T cells) are recruited to the central nervous system by chemokines secreted by immune cells in the brain, where they interact with central nervous system cells (mainly microglia) to trigger a secondary neuroimmune response. This review summarizes the interactions between T cells and microglia in the immune-inflammatory processes of ischemic stroke. We found that, during ischemic stroke, T cells and microglia demonstrate a more pronounced synergistic effect. Th1, Th17, and M1 microglia can co-secrete proinflammatory factors, such as interferon-γ, tumor necrosis factor-β, and interleukin-1α, to promote neuroinflammation and exacerbate brain injury. Th2, Treg, and M2 microglia jointly secrete anti-inflammatory factors, such as interleukin-4, interleukin-10, and transforming growth factor-β, to inhibit the progression of neuroinflammation, as well as growth factors such as brain-derived neurotrophic factor to promote nerve regeneration and repair brain injury. Immune interactions between microglia and T cells influence the direction of the subsequent neuroinflammation, which in turn determines the prognosis of ischemic stroke patients. Clinical trials have been conducted on the ways to modulate the interactions between T cells and microglia toward anti-inflammatory communication using the immunosuppressant fingolimod or overdosing with Treg cells to promote neural tissue repair and reduce the damage caused by ischemic stroke. However, such studies have been relatively infrequent, and clinical experience is still insufficient. In summary, in ischemic stroke, T cell subsets and activated microglia act synergistically to regulate inflammatory progression, mainly by secreting inflammatory factors. In the future, a key research direction for ischemic stroke treatment could be rooted in the enhancement of anti-inflammatory factor secretion by promoting the generation of Th2 and Treg cells, along with the activation of M2-type microglia. These approaches may alleviate neuroinflammation and facilitate the repair of neural tissues.

Role of transcription factors, noncoding RNAs, epitranscriptomics, and epigenetics in post‐ischemic neuroinflammation

Inflammatory Responses in Brain Ischemia

MicroRNAs Modulate Neuroinflammation after Intracerebral Hemorrhage: Prospects for New Therapy.

The Evolving Role of Neuro-Immune Interaction in Brain Repair after Cerebral Ischemic Stroke

Emerging Role of LncRNAs in Ischemic Stroke—Novel Insights into the Regulation of Inflammation

Inflammation Mediates Varying Effects in Neurogenesis: Relevance to the Pathogenesis of Brain Injury and Neurodegenerative Disorders

Post-ischemic inflammatory response in the brain: Targeting immune cell in ischemic stroke therapy

Non-coding RNAs in Ischemic Stroke: Roles in the Neuroinflammation and Cell Death

T cell interactions with microglia in immuneinflammatory processes of ischemic stroke

Inflammation in Ischaemic Brain Injury: Current Advances and Future Perspectives.

Molecular Dialogs Between the Ischemic Brain and the Peripheral Immune System: Dualistic Roles in Injury and Repair.

Focused Update on Stroke Neuroimmunology: Current Progress in Preclinical and Clinical Research and Recent Mechanistic Insight.

Unraveling the protein post-translational modification landscape: Neuroinflammation and neuronal death after stroke

The impact of cytokines in neuroinflammation-mediated stroke

Communications Between Peripheral and the Brain-Resident Immune System in Neuronal Regeneration After Stroke

Neuroinflammation and Brain-Peripheral Interaction in Ischemic Stroke: A Narrative Review

Targeting brain-peripheral immune responses for secondary brain injury after ischemic and hemorrhagic stroke

Crosstalk between Nrf2 signaling pathway and inflammation in ischemic stroke: Mechanisms of action and therapeutic implications

Inflammation after Ischemic Stroke: The Role of Leukocytes and Glial Cells

The role of neuro-inflammatory in the pathogenesis of brain edema and hemorrhagic transformation in ischemic stroke: mechanisms and therapeutic target

Proinflammatory and Anti-inflammatory Genes in Stroke Pathogenesis